Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Herr

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
The Journal of Urology|March 1, 1988
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Progress in Clinical and Biological Research|January 1, 1988
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapyC N Sternberg, A Yagoda, H I Scher, et al.
Journal of the American College of Surgeons|May 1, 1995
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990G W Jones, C Mettlin, G P Murphy, et al.
Progress in Clinical and Biological Research|January 1, 1988
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
Critical Reviews in Oncology/Hematology|February 1, 1994
Bladder cancer: advances in biology and treatmentG J Bosl, W R Fair, H W Herr, et al.
The Journal of Urology|March 1, 1988
M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
The Journal of Urology|March 1, 1988
Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumorsH I Scher, A Yagoda, H W Herr, et al.
Progress in Clinical and Biological Research|January 1, 1988
Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapyC N Sternberg, A Yagoda, H I Scher, et al.
Journal of the American College of Surgeons|May 1, 1995
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990G W Jones, C Mettlin, G P Murphy, et al.
Progress in Clinical and Biological Research|January 1, 1988
M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urotheliumC N Sternberg, A Yagoda, H I Scher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1990
Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selectionG C Toner, D M Panicek, R T Heelan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with metastatic nonseminomatous germ cell tumors of the testisP C Brenner, H W Herr, M J Morse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapseF Rabbani, J Sheinfeld, H Farivar-Mohseni, et al.
Pageof 28